Last edition
News about
PharmaJet, a commercial-stage global leader in needle-free injection systems, has announced the expansion of its manufacturing portfolio with the development of a suite of proprietary, needle-free self-injector pens.
CTx001, an AAV-based gene therapy, delivers a mini-CR1 protein to modulate complement pathways and address Geographic Atrophy (GA), an advanced dry AMD causing irreversible vision loss.
Zenas BioPharma Signs USD 2 Billion Licensing Deal with InnoCare for Autoimmune Drugs
Zenas BioPharma has entered into a licensing agreement with China’s InnoCare Pharma worth up to USD 2 billion to develop and commercialise three autoimmune drug candidates, including a late-stage treatment for multiple sclerosis.
Turbine Partners with AstraZeneca to Accelerate Antibody-Drug Conjugate Discovery
Turbine, a leading company specialising in virtualising biological experiments through artificial intelligence (AI), has announced a new collaboration with AstraZeneca to enhance the discovery of antibody-drug conjugates (ADCs).
CND Life Sciences has received FDA Breakthrough Device Designation for its Syn-One Test, designed to aid in diagnosing synucleinopathies in patients aged 40 years and above with neurological symptoms.
Lupin Launches Strategic Partnership Programme to Expand Reach of PrecisionSphere
Global pharma major Lupin has launched a strategic partnership programme aimed at expanding the reach of PrecisionSphere – the long-acting injectable (LAI) platform developed by its subsidiary, Nanomi.
Lupin to Invest USD 250 Million in New USA Respiratory Drug Manufacturing Facility in Florida
Lupin has announced plans to invest USD 250 million over the next five years to establish a new state-of-the-art manufacturing facility in Coral Springs, Florida. The facility will focus on producing over 25 essential respiratory medicines, including albuterol inhalers.
Kernal Biologics receives USD 48 Million from ARPA-H
The funding received by Kernal Biologics from ARPA-H is to develop lower cost in vivo CAR T-cell therapies for hematological cancers.
Edan Instruments Expands US Footprint with New Manufacturing Hub in San Diego
Chinese medical device manufacturer EDAN Instruments has strengthened its presence in the United States with the opening of a new manufacturing hub in San Diego, California.
Panacea Biotec Secures INR Over 127 Crore Order for Bivalent Oral Polio Vaccine from CMSS
The Central Medical Services Society (CMSS), under the Ministry of Health and Family Welfare, Government of India, has awarded Panacea Biotec a contract to supply bivalent oral polio vaccine (bOPV) worth INR 127.20 Crore.
We use our own and third party cookies to produce statistical information and show you personalized advertising by analyzing your browsing, according to our COOKIES POLICY. If you continue visiting our Site, you accept its use.
More information: Privacy Policy